EC Number   |
Disease   |
PubMed ID   |
Title of Publication   |
Category   |
Confidence Level   |
|---|
 3.1.3.56 | Carcinoma |
25759212 |
A distinct and replicable variant of the squamous cell carcinoma gene inositol polyphosphate-5-phosphatase modifies the susceptibility of arsenic-associated skin lesions in Bangladesh. |
ongoing research |
1 |
 3.1.3.56 | Carcinoma |
25759212 |
A distinct and replicable variant of the squamous cell carcinoma gene inositol polyphosphate-5-phosphatase modifies the susceptibility of arsenic-associated skin lesions in Bangladesh. |
unassigned |
0 |
 3.1.3.56 | Carcinoma, Squamous Cell |
25759212 |
A distinct and replicable variant of the squamous cell carcinoma gene inositol polyphosphate-5-phosphatase modifies the susceptibility of arsenic-associated skin lesions in Bangladesh. |
ongoing research |
1 |
 3.1.3.56 | Carcinoma, Squamous Cell |
25759212 |
A distinct and replicable variant of the squamous cell carcinoma gene inositol polyphosphate-5-phosphatase modifies the susceptibility of arsenic-associated skin lesions in Bangladesh. |
unassigned |
0 |
 3.1.3.56 | Neoplasm Metastasis |
33798953 |
A new gene panel as a marker for ESCC poor prognosis; INPP5A, TWIST1, MMP2, and EGFR. |
causal interaction |
4 |
 3.1.3.56 | Neoplasm Metastasis |
33798953 |
A new gene panel as a marker for ESCC poor prognosis; INPP5A, TWIST1, MMP2, and EGFR. |
unassigned |
0 |
 3.1.3.56 | Neoplasms |
33798953 |
A new gene panel as a marker for ESCC poor prognosis; INPP5A, TWIST1, MMP2, and EGFR. |
causal interaction |
4 |
 3.1.3.56 | Neoplasms |
33798953 |
A new gene panel as a marker for ESCC poor prognosis; INPP5A, TWIST1, MMP2, and EGFR. |
unassigned |
0 |
 3.1.3.56 | Oculocerebrorenal Syndrome |
23692838 |
A novel OCRL1 gene mutation in a Turkish child with Lowe syndrome. |
causal interaction |
3 |
 3.1.3.56 | Oculocerebrorenal Syndrome |
23692838 |
A novel OCRL1 gene mutation in a Turkish child with Lowe syndrome. |
therapeutic application |
1 |